Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
JBCHEPHARM | BSE
-43.65
-2.91%
Healthcare
Drug Manufacturers-Specialty & Generic
30/09/2023
08/12/2023
1,454.75
1,515.00
1,516.50
1,439.95
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations herbal remedies and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine Ranitidine and Metronidazole. The company also provides contract manufacturing services for tablets lozenges injectables gels creams ointments liquid herbal syrups and capsules; and soft-centered powder medicated and herbal lozenges as well as various pharmaceutical dosage forms. In addition it offers a range of contrast media products including x-ray magnetic resonance imaging (MRI) and ultrasound scanners. Further the company provides its services in gastroenterology hypertension diabetes dermatology nephrology wound care anti-infectives and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai India.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Weakness based on declining price with high volume
High 6-Month Volatility (>65%)
Midcap (2B - 10B USD)
Weak P/E, and PEG ratio indicator
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
30.6%1 month
28.4%3 months
108.1%6 months
81.1%47.17
32.47
8.29
0.17
0.12
27.02
6.77
0
8.15B
225.74B
2.71B
0.64
23.97
33.80
8.90
19.34
0
0
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
177.85
Range1M
177.85
Range3M
1.80K
Rel. volume
1.82
Price X volume
17.54M